AI across the RNA therapeutics lifecycle: discovery, development, and the road to personalized medicine

Jokūbas Leikauskas, Editor, Nucleic Acid Insights, speaks with Edward Miracco, Head of Enterprise AI Enablement, Moderna, about enterprise AI adoption, AI-driven lipid nanoparticle and neoantigen design, rare disease applications of mRNA, and the future of RNA therapeutics.

Authors

Institutions

Publication Details

Journal
Nucleic Acid Insights
Published
2026-11-12
DOI
https://doi.org/10.18609/nai.2026.084
Primary Topic
RNA Interference and Gene Delivery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

AI across the RNA therapeutics lifecycle: discovery, development, and the road to personalized medicine

Edward Miracco
Nucleic Acid Insights
RNA Interference and Gene Delivery
article

AI across the RNA therapeutics lifecycle: discovery, development, and the road to personalized medicine

Edward Miracco
article en

Abstract

Jokūbas Leikauskas, Editor, Nucleic Acid Insights, speaks with Edward Miracco, Head of Enterprise AI Enablement, Moderna, about enterprise AI adoption, AI-driven lipid nanoparticle and neoantigen design, rare disease applications of mRNA, and the future of RNA therapeutics.

Nucleic Acid InsightsVol. 3(9)
Moderna Therapeutics (United States) (US)
RNA Interference and Gene Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon